Skip to main content
. 2015 Aug 21;51(2):790–811. doi: 10.1111/1475-6773.12355

Table 3.

Second‐Stage Cox Proportional Hazard Models: Effect of Sulfonylureas (SU) on Mortality, Ambulatory Care–Sensitive Condition (ACSC) Hospitalization, and Cardiovascular Outcomes (n = 80,936)

Hazard Ratio P < |t| 95% Confidence Interval
All‐cause mortality 1.50 0.014 1.09–2.09
ACSC hospitalization 1.68 <0.001 1.31–2.15
Stroke or heart attack 1.15 0.457 0.80–1.66

Models include baseline demographics, Elixhauser comorbidities, Young severity index, HbA1c, BMI, microalbumin, serum creatinine, provider quality controls, year fixed effects, and Veterans Affairs Medical Center random effects.

Source. Excerpted from Prentice et al. (2014, table 4).